Literature DB >> 33477833

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma.

Caecilia H C Sukowati1, Loraine Kay D Cabral1,2, Claudio Tiribelli1, Devis Pascut1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide, partially due to late diagnosis of the disease. Growing evidence in the field of biomarker discovery has shown the promising use of nucleic acid in the early detection of many cancers, including HCC. Here, we review data on how various long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) could be used as a diagnostic tool for HCC being differentially expressed in HCC compared to non-HCC patients. These non-coding RNAs (ncRNAs) showed high stability in the blood being present as free-circulating molecules or encapsulated into exosomes. This review reports some recent evidence on the use of lncRNAs and circRNAs as possible diagnostic biomarkers for HCC. Further, their pathophysiological mechanism in liver carcinogenesis was also described, elucidating the complex regulatory networks making these ncRNAs of particular relevance for the study of liver malignancy cancer.

Entities:  

Keywords:  circRNA; diagnosis; hepatocellular carcinoma; lncRNA; ncRNAs; non-invasive biomarker

Year:  2021        PMID: 33477833      PMCID: PMC7832835          DOI: 10.3390/biomedicines9010090

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  139 in total

Review 1.  The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.

Authors:  Xian Chen; Limin Lun; Huabin Hou; Runhua Tian; Haiping Zhang; Yunyuan Zhang
Journal:  Cell Physiol Biochem       Date:  2017-03-17

2.  Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.

Authors:  Wei Wang; Yuan Li; Xiuling Li; Bowei Liu; Shuangyin Han; Xiaofang Li; Bingyong Zhang; Jian Li; Suofeng Sun
Journal:  Biomed Pharmacother       Date:  2019-11-04       Impact factor: 6.529

Review 3.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

4.  Diagnostic value of long non-coding RNA H19, UCA1, and HOTAIR as promising biomarkers in human bladder cancer.

Authors:  Wei Wang; Zhihua Yin
Journal:  Int J Clin Exp Pathol       Date:  2017-12-01

5.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

6.  Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma.

Authors:  Li-Chao Xu; Quan-Ning Chen; Xi-Qiang Liu; Xiao-Ming Wang; Qi-Meng Chang; Qi Pan; Lu Wang; Yi-Lin Wang
Journal:  Oncotarget       Date:  2017-04-11

7.  Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis.

Authors:  Yuhui Li; Hongliang Zang; Xue Zhang; Guomin Huang
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

8.  X-inactive-specific transcript of peripheral blood cells is regulated by exosomal Jpx and acts as a biomarker for female patients with hepatocellular carcinoma.

Authors:  Xiang Ma; Tingdong Yuan; Chao Yang; Zusen Wang; Yunjin Zang; Liqun Wu; Likun Zhuang
Journal:  Ther Adv Med Oncol       Date:  2017-09-21       Impact factor: 8.168

9.  Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.

Authors:  Guifang Yu; Jieheng Lin; Chengcheng Liu; Kailian Hou; Min Liang; Boyun Shi
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

10.  Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Zhi-Kun Zheng; Cui Pang; Yang Yang; Qiong Duan; Ju Zhang; Wen-Chao Liu
Journal:  J Int Med Res       Date:  2017-08-31       Impact factor: 1.671

View more
  9 in total

Review 1.  Long Noncoding RNAs and Human Liver Disease.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Annu Rev Pathol       Date:  2021-08-20       Impact factor: 32.350

Review 2.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

Review 3.  Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Authors:  Min Yao; Jun-Ling Yang; De-Feng Wang; Li Wang; Ying Chen; Deng-Fu Yao
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

Review 4.  Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals.

Authors:  Loraine Kay D Cabral; Luca Grisetti; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

Review 5.  Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.

Authors:  Nia Adeniji; Renumathy Dhanasekaran
Journal:  Hepatol Commun       Date:  2021-09-17

6.  Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.

Authors:  Fenfen Wang; Zhengyuan Xie; Nuobei Zhang; Hao Ding; Kai Xiong; Li Guo; Hongyan Huang; Zhili Wen
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 7.  The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.

Authors:  Wei Wang; Li-Ping Hao; Haizhu Song; Xiao-Yuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 8.  The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma.

Authors:  Jingnuo Ding; Weifeng Zhao
Journal:  Cancer Manag Res       Date:  2022-09-15       Impact factor: 3.602

9.  CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.

Authors:  Mingyu Chu; Yaqun Fang; Yucui Jin
Journal:  J Clin Lab Anal       Date:  2021-07-31       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.